AbbVie Inc., prevailed in the latest bellwether trial accusing the company’s testosterone treatment AndroGel of causing heart attacks, strokes and blood clots, but AbbVie and other testosterone manufacturers still face thousands more lawsuits consolidated in a multidistrict litigation in the U.S. District Court for the Northern District of Illinois. This is the third of five bellwether trials that have been won by testosterone makers. The other two have resulted in a total of $143 million in verdicts for the plaintiffs. The latest trial involved the case of Rober Rowley who was prescribed AndroGel in 2012 to treat fatigue. Years earlier, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.